Written by Meguid El Nahas
on Wednesday, 23 November 2016.
Posted in OLA Blog

Prof Richard Glassock wrote:
I went to a session on Onco-Nephrology at the ASN meeting yesterday.
Two randomized controlled trials of high-cut off (HCO) membrane intermittent hemodialysis compared to standard membrane hemodialysis for...

Written by Meguid El Nahas
on Sunday, 20 November 2016.
Posted in OLA Blog

Prof Arif Khwaja Reporting from Chicago:
Late Breaking Clinical Trials
LEADER study looking at Liraglutatide on renal outcomes in patients with T2DM. This was a huge study with over 8000 patients with T2DM at higher CV risk who were randomised...

Written by Neveen A Soliman
on Wednesday, 05 October 2016.
Posted in OLA Blog

During the plenary session of the first day of the 17th International Pediatric Nephrology A ssociation Congress, September 20-24 in Iguacu, Brazil
Professor Moin A Saleem delivered the keynote talk entitled “Molecular...